(Q47653019)

4 February 2018

title

Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk (English)

1 reference

4 February 2018

author name string

Elif Akisik

series ordinal

1

1 reference

4 February 2018

Nejat Dalay

series ordinal

2

1 reference

4 February 2018

publication date

1 June 2004

1 reference

4 February 2018

Experimental and Molecular Pathology

published in

1 reference

4 February 2018

volume

76

1 reference

4 February 2018

issue

3

1 reference

4 February 2018

page(s)

260-263

1 reference

4 February 2018

Re: population-based, case-control study of HER2 genetic polymorphism and breast cancer risk

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

Ethnic variation in the HER-2 codon 655 genetic polymorphism previously associated with breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

inferred from DOI database lookup

7 January 2021

based on heuristic

DNA polymorphism in B-domain of the estrogen receptor-alpha among Japanese women

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

The use of FISH on breast core needle samples for the presurgical assessment of HER-2 oncogene status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

Polymorphisms in the estrogen receptor-alpha gene and breast cancer risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

Distribution of HER2 V655 genotypes in breast cancer cases and controls in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

An estrogen receptor genetic polymorphism and a history of spontaneous abortion--correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

Genotype distribution of estrogen receptor-alpha gene polymorphisms in Italian women with surgical uterine leiomyomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

Estrogen receptor antibodies: specificity and utility in detection, localization and analyses of estrogen receptor alpha and beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

Polymorphisms of estrogen receptor alpha gene in endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers: correlation to clinical features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

c-erbB-2 gene amplification in nasopharyngeal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.12.005

10.1016/J.YEXMP.2003.12.005

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018